TBA (last known deadline was November 12, 2012)
The National Lung Cancer Partnership and Uniting Against Lung Cancer announce a new funding opportunity intended to accelerate the movement of promising ideas in lung cancer research into clinical application. Our organizations are both dedicated to funding research aimed at improved treatments and a cure for lung cancer; we are partnering to offer a single award of $200,000 to rapidly bring new advances to the clinic and positively impact patient care.
This award is intended to support clinical translational research that will promote significant improvements over current approaches in lung cancer prevention, detection or therapy. Applicants are expected to demonstrate an ability to produce significant progress for lung cancer patients in the near term.